HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Serum thymidine kinase 1 activity in breast cancer.

AbstractAIMS:
Thymidine kinase 1 (TK1) is an enzyme involved in DNA synthesis and an important proliferation marker. We explored the association of preoperative serum TK1 activity with clinicopathological parameters and prognosis in terms of recurrence-free survival (RFS) in breast cancer (BC) patients.
PATIENTS AND METHODS:
TK1 activity in serum of 120 healthy women and 161 BC patients was measured by quantitative ELISA.
RESULTS:
Serum TK1 activity in BC patients was significantly higher than in healthy women (P < 0.0001). In BC patients elevated TK1 activity was significantly associated with advanced T stage (P = 0.015), higher grade (P = 0.013), presence of tumor necrosis (P = 0.006), vascular invasion (P = 0.002), and lack of estrogen receptor (ER) and progesterone receptor (PR) expression (P = 0.0004 and P = 0.003). Higher TK1 activity was found in patients with BRCA1/2 mutations compared to those without the mutation (P = 0.004). Multivariate Cox proportional hazards analyses demonstrated that TK1, adjusted for stage, grade, necrosis, ER and PR negativity was retained as an independent predictor of disease recurrence (Hazard Ratio = 3.9, 95%CI 1.3-11.6, P = 0.013).
CONCLUSION:
Elevated serum TK1 is an important risk factor indicating a high proliferation potential of tumors at the time of excision. In multivariate analysis TK1 activity was found to be an independent prognostic factor for RFS.
AuthorsBenjamin Nisman, Tanir Allweis, Luna Kaduri, Bella Maly, Simon Gronowitz, Tamar Hamburger, Tamar Peretz
JournalCancer biomarkers : section A of Disease markers (Cancer Biomark) Vol. 7 Issue 2 Pg. 65-72 ( 2010) ISSN: 1875-8592 [Electronic] Netherlands
PMID21178264 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Biomarkers, Tumor
  • Receptors, Estrogen
  • Receptors, Progesterone
  • Thymidine Kinase
  • thymidine kinase 1
Topics
  • Adult
  • Aged
  • Biomarkers, Tumor (blood)
  • Breast Neoplasms (blood, enzymology, pathology)
  • Case-Control Studies
  • Disease-Free Survival
  • Female
  • Humans
  • Middle Aged
  • Neoplasm Recurrence, Local (pathology)
  • Neoplasm Staging
  • Predictive Value of Tests
  • Prognosis
  • Prospective Studies
  • Receptors, Estrogen (metabolism)
  • Receptors, Progesterone (metabolism)
  • Risk Factors
  • Thymidine Kinase (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: